Digital Health

BehaVR and OxfordVR Merge; Raise $13M in Series B Funding to Create a VR Delivery Platform for Evidence-Based Digital Therapeutics

Virtual reality mental and behavioral health companies BehaVR and OxfordVR today announced their merger, supported by an initial $13 million in Series B funding led by Optum Ventures and Oxford Science Enterprises, with participation from Confluent Health, Accenture Ventures, Chrysalis Ventures and Thornton Capital. The combination of the two digital therapeutic companies creates the largest VR delivery platform for evidence-based digital behavioral therapies and accelerates the combined company’s growth strategy. Globally, roughly one billion people are living with…

Nuvo Pairs INVU, Its Remote Monitoring Solution, with Ouma’s Telehealth Services to Deliver End-to-End Pregnancy Care

Nuvo, the company behind of INVU, an FDA-approved remote pregnancy monitoring platform, is partnering with Ouma Health, a maternity telehealth services company, to deliver an innovative joint solution that provides clinical excellence in maternity telehealth and FDA-cleared remote fetal surveillance technology. The joint solution is designed to address some of the biggest challenges in pregnancy care today, by enabling equitable access to care, improving…

ROI and Clinical Validation Will Be the Greatest Markers of Success in 2023 According to Top Digital Health Investors

Investors in the healthcare technology space believe a measurable return on investment (ROI) and clinical validation of the technology’s platform will be the greatest indicators of company success in 2023, according to a new survey of top digital health investors by GSR Ventures. ROI was deemed “important” or “very important” to the success of digital health companies by more than 94% of investor respondents,…

Genetic Testing Company JunoDx Launches Juno Hazel, Its Non-invasive Prenatal Screening Solution

Genetic testing company JunoDx has announced the launch of Juno Hazel, a new non-invasive prenatal screening (NIPS) solution enabled from finger-prick amounts of blood. The Juno Hazel test breaks through one of the most significant barriers to access for genetic testing by leveraging JunoDx’s proprietary Sample Collection Kit. This process improves early access to high-quality genetic testing without the high costs, long…

Endometriosis DTx Endo-App Is Now Reimbursed as a Prescription Digital Health Product (DiGA) in Germany

Last month the German government added Endo-App, a digital therapeutic for endometriosis sufferers, to its DiGA directory after the app successfully completed the Federal Institute for Drugs and Medical Devices’ (in German: Bundesinstitut für Arzneimittel und Medizinprodukte aka BfArM) assessment procedure. The DiGa database is essentially a collection of regulated digital health products reimbursed via the government’s fast-track program. Per definition DiGAs are CE-marked medical devices…

UK-based Luna Launches Its App for Teen Health & Wellbeing with £600K in Pre-seed Funding

Luna, a UK-based startup focused on teen health and wellbeing has raised £600K in pre-seed funding to launch its app, and support young people aged 11-17 on their journey to adulthood. Participants in this round include Maria Ro and Kirsten Connell of Octopus Ventures and Miruna Girtu of Syndicate Room. Launched today, the new app is the first of its kind on…

FOLX Health Adds $30M in Series B Funding; Now Offers Family Planning and Fertility Services

  FOLX Health, the digital healthcare service provider designed by and for the medical needs of the LGBTQIA+ community has raised a $30M Series B led by 7wireVentures. Other participants in the round include Foresite Capital, Bessemer Venture Partners, Define Ventures, and Polaris Partners. FOLX Health will use the new funds to continue expanding its platform to service members, self-insured employers and…

Shimmer Launches with $1.3M in Seed Funding to Make ADHD Coaching More Accessible

The neurodevelopmental condition known as attention-deficit/hyperactivity disorder (ADHD) is massive; according to the renowned ADHD authority, Dr. Russell A. Barkley, Ph.D., 13 million American adults (4-5%) deal with its impacts every day. ADHD may make it difficult to regulate emotions and complete everyday tasks at work and at home. It often leads to anxiety, depression, relationship problems, personal/professional stress and disruption, substance abuse, and…